Explore Gilead Sciences' Q3 2025 earnings: strong HIV portfolio growth, Yeztugo's rapid launch, and raised guidance.

Funding cuts from federal programs threaten HIV care in Columbia as PALSS fights to keep vital health, housing, and food ...

Richard says it took two days for a qualified interpreter to arrive and explain he had been given the all-clear. "If an ...

GLAAD--the world's largest lesbian, gay, bisexual, transgender, and queer (LGBTQ) media advocacy organization––invited Snoop ...

Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...

Clade I, the version of mpox now circulating in Southern California, is not new to science. It’s been responsible for severe ...

Two owners of Cambridge-based Safe Chain Solutions have been found guilty of multiple charges including introducing black ...

More than 230 people became infected with HIV in Indiana, worsened by delayed action from former Gov. Mike Pence. Experts and ...

Patrick and Charles Boyd bought more than $90 million of the illicit drugs and sold them to unwitting customers in South ...

Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...

Fans of social media star Mainly Mannie are showing their support after he shared an update on his health online.

More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...